大鼠肺细小动脉平滑肌细胞培养新方法的建立及血小板衍生因子对其增殖迁移的影响

目的：建立一种操作简单、实验仪器要求低的大鼠肺细小动脉平滑肌细胞（PASMCs）分离和培养的方法,并且探索血小板衍生因子（PDGF）介导的增殖、迁移的情况。方法：向右心注射铁及琼脂糖,利用琼脂糖能同时粘附血管内皮细胞、平滑肌细胞及铁粉,再结合胶原酶I的消化,通过磁力架吸引铁,特异性地分选出带血管的肺组织,经过3~4周左右的培养及纯化,得到肺细小动脉平滑肌细胞。用倒置相差显微镜观察细胞形态,免疫细胞化学法和免疫荧光染色法进行α-平滑肌肌动蛋白鉴定。MTT实验和划痕实验检测PDGF诱导的肺动脉细小平滑肌细胞的增殖和迁移。结果：分离后第14天、第21天及传代后进行鉴定,均表明分离培养的细胞为PASMCs。MTT结果表明,与不加PDGF组相比,PDGF增殖明显增加（P<0.05）。划痕实验结果显示PDGF刺激组比不刺激组迁移显著增多。结论：本方法分离培养大鼠的PASMCs,操作方便,实验仪器要求低。PDGF能够促进肺细小动脉平滑肌细胞的增殖、迁移。     

SD大鼠胸腹主动脉平滑肌细胞的原代培养及鉴定

目的建立原代大鼠胸腹主动脉平滑肌细胞培养方法,为研究心脑血管动脉粥样硬化疾病提供重要的载体和工具细胞。方法选取6～8周龄SD大鼠2只,剪开胸腹腔,剥离主动脉,刮除血管内、外膜,经0.2%Ⅱ型胶原酶/弹性蛋白酶消化后,剪碎成块,种瓶进行原代培养。通过细胞形态学观察、α平滑肌肌动蛋白免疫细胞化学染色法鉴定所培养的目的细胞。结果接种于培养瓶中的血管组织块培养48h后开始贴壁;72h后细胞以组织块为中心,向外迁移,"岛屿状"细胞团簇初步形成;96h后原代细胞集落逐渐融合,铺满瓶底,呈现典型的"峰-谷"样生长;第一代传代细胞形态基本保持不变,高倍镜下细胞呈三角形或星形。免疫细胞化学染色显示,细胞α平滑肌肌动蛋白阳性率达99%以上。结论复合酶消化法结合组织块法能够成功高效地分离培养出原代大鼠胸腹主动脉平滑肌细胞。     

密度梯度离心法同时分离新生大鼠原代心肌细胞与成纤维细胞

本文旨在探讨一种改良的同时分离新生大鼠原代心肌细胞和成纤维细胞的方法,以建立良好的原代心肌细胞及成纤维细胞研究模型。无菌状态下取Wistar乳鼠(出生不超过2天)心室,用II型胶原酶消化,控制消化时间及次数、搅拌速度、离心次数和速度等,结合Percoll密度梯度离心法分离心肌细胞及成纤维细胞,进行体外培养,观察细胞形态,继而用0.2%台盼蓝染色检测细胞存活率,免疫荧光染色法检测心肌肌钙蛋白I(cardiac troponin I,c Tn I)、波形蛋白(Vimentin)及α平滑肌肌动蛋白(α-smooth muscle actin,α-SMA)的表达,分别用于鉴定心肌细胞和成纤维细胞纯度。结果显示,本方法5次分离的心肌细胞平均存活率达92%,纯度达95%以上,细胞生长状态良好,可见贴壁自发搏动;成纤维细胞平均存活率达96%,纯度达94%。本方法能同时获得新生大鼠原代心肌细胞和成纤维细胞,具有很高的产量、存活率及纯度,且操作简便,耗时短,重复性好,是一种较为理想的原代细胞分离、培养方法,可满足各种后续实验要求。     

成年SD大鼠心肌原代成纤维细胞分离及培养的优化方案

目的:摸索及优选成年SD大鼠心肌原代成纤维细胞的体外分离、培养及鉴定的实验方法。方法:将成年SD大鼠心脏剪成小组织块,采用以下四种方案(A:0.08%胰酶+0.1%胶原酶II消化15 min,B:0.2%胶原酶II消化15 min,C:0.2%胶原酶II消化60min,D:0.2%胶原酶II消化90 min)提取成年大鼠心脏原代成纤维细胞,再通过差速贴壁分离方法培养原代成纤维细胞。采用倒置显微镜观察成纤维细胞的基本形态特征,并进行Vimentiin免疫荧光染色对培养的原代细胞进行荧光鉴定;采用台盼兰染色对培养的原代成纤维细胞存活率进行鉴定;采用细胞计数对培养的成纤维细胞生长趋势进行鉴定。结果:四种方法均能培养成纤维细胞,但单酶消化60 min可一次性提取较多细胞,并且细胞状态佳,3 d即可传代。72 h成纤维细胞Vimentin免疫荧光染色阳性率高达97%。台盼兰染色可见其细胞死亡率明显降低,并且细胞计数可见细胞生长状态极佳。结论:单酶消化60 min是提取成年SD大鼠心肌原代成纤维细胞的高效、快速、稳定的实验方法,为心脏疾病的基础及临床研究提供了较为理想的细胞学实验模型。     

前列腺基质细胞的原代培养方法

目的:建立一种操作简单、成功率高、重复性好的前列腺增生组织原代基质细胞(PSC)培养方法。方法:采用胶原酶消化法、组织块贴壁法和胰酶消化组织块贴壁法,从70岁及以上男性的良性前列腺增生组织中分离培养PSC,通过显微镜观察比较PSC的数量、形态、培养周期,用免疫荧光染色法鉴定PSC的纯度。结果:胶原酶消化法得到的贴壁细胞少,细胞体积较小且形态无法铺展,增殖能力较弱;组织块贴壁法培养72h后细胞会从组织边缘缓慢爬出,生长周期长;胰酶消化组织块贴壁法,细胞培养7d后基本融合,折光性强,细胞多呈长梭形,通过免疫荧光染色鉴定,基质细胞纯度在95%以上。结论:利用胰酶消化组织块贴壁法建立了一种易行、高效且重复性好的前列腺增生组织基质细胞培养方法。     

人妊娠子宫平滑肌细胞的原代培养Transgelin蛋白的检测

为了建立最佳的人妊娠子宫平滑肌细胞的原代培养方法和初步检测子宫平滑肌细胞中Transgelin蛋白的表达,采用组织块贴壁法和酶消化法进行人妊娠子宫平滑肌原代培养.发现组织贴块培养的细胞呈典型的梭状肌细胞样生长,经过传代纯化,通过免疫细胞化学方法检测平滑肌肌动蛋白(smooth muscle acting,SMA)进行细胞鉴定及检测Trangsgelin(smooth muscle 22 alpha,SM22-α)蛋白,得到SMA、snd2-α荧光免疫细胞化学染色为阳性.结果表明组织贴块法对妊娠子宫平滑肌细胞损伤小,可获得状态良好的纯净的子宫平滑肌细胞,子宫平滑肌细胞中大量表达sm2-α,为进一步研究sm22-α在子宫平滑肌细胞中作用打下基础.     

改良组织块消化法建立大鼠气道平滑肌细胞模型

目的：建立改进大鼠气道平滑肌细胞（ASMC）的体外培养方法,为相关研究提供实验材料。方法：将组织块连续贴壁进行细胞原代培养,胰酶消化传代培养,差速贴壁进行细胞纯化,形态学及免疫细胞化学染色法进行细胞鉴定。MTT法检测PDGF-BB诱导的ASMC增殖。结果：成功培养大鼠ASMC,以改良组织块消化法最为理想。第四代平滑肌细胞纯度可达95％以上。相差显微镜下培养细胞呈典型“峰谷状”生长。免疫荧光化学染色显示特异性平滑肌肌动蛋白阳性表达。随着PDGF浓度的升高（2-80ng／ml）,MTT比色A490值呈上升趋势。与对照组相比较,80ng／ml、20ng／ml PDGF—BB组有统计学意义（P〈0．01）。结论：改良组织块消化法可缩短培养周期,在充分利用标本的基础上获得大量气道平滑肌细胞。     

大鼠髓核细胞原代培养及表型鉴定

目的:探讨Ⅱ型胶原酶联合透明质酸酶消化分离培养髓核细胞及免疫细胞化学表型鉴定的可行性。方法:无菌条件下分离SD大鼠凝胶状髓核,采用Ⅱ型胶原酶联合透明质酸酶消化分离髓核细胞并连续培养,倒置相差显微镜下观察,随后进行免疫细胞化学染色检测不同代次髓核细胞HIF-1、Ⅰ、Ⅱ型胶原、MMP2及蛋白聚糖的表达情况,并给予MTT法测定髓核细胞生长曲线。结果:Ⅱ型胶原酶联合透明质酸酶分离培养原代髓核细胞需要12 d左右贴壁,达95%融合需要34 d,而传代髓核细胞贴壁速率明显增快至10 h,且其倍增时间约为2.5 d;免疫细胞化学显示髓核细胞均表达HIF-1、Ⅰ、Ⅱ型胶原、MMP2和蛋白聚糖,且随着髓核细胞传代其HIF-1α、HIF-1β、Ⅰ型胶原及MMP2表达均增加,但Ⅱ型胶原表达降低,而蛋白聚糖表达无明显差异;MTT法显示随着髓核细胞传代其增殖有所减缓。结论:Ⅱ型胶原酶联合透明质酸酶可成功分离髓核细胞,提高培养效率,且HIF-1α、HIF-1β、Ⅰ、Ⅱ型胶原及MMP2可作为髓核细胞表型分子用于髓核细胞的鉴定。     

小鼠主动脉平滑肌细胞的分离培养及鉴定

目的:建立分离培养小鼠原代主动脉血管平滑肌细胞(VSMC)的方法并检测其生长特性。方法:剥离小鼠主动脉中膜层,分别采用组织块培养法及胶原酶消化法分离培养小鼠主动脉来源的原代VSMC,免疫荧光法检测细胞的纯度和分化状态;3-(4,5-二甲基-2-噻唑)-2,5-二苯基溴化四氮唑蓝(MTT)法测定小鼠主动脉VSMC传代细胞的生长、增殖特性。结果:组织块培养法培养组织块8d后,细胞从组织块边缘爬出,18 d后细胞汇合度达到80%以上后传代;胶原酶消化法分离培养的细胞生长7 d后,汇合度可达80%,此时进行传代;2种方法获得的细胞进行免疫荧光染色,结果显示细胞传至第3代时纯度在95%以上,传至第8代时分化状态并没有改变;MTT法显示细胞生长3~5 d时处于指数生长期。结论:本研究建立了2种可靠稳定的分离和培养小鼠主动脉VSMC的方法,VSMC纯度高,多次传代后细胞特征稳定。     

大鼠膝骨关节炎滑膜细胞原代培养

目的:建立原代培养膝骨关节炎大鼠滑膜细胞的方法。方法:取膝骨关节炎大鼠膝关节滑膜组织,用酶消化法消化、分离细胞,用DMEM培养液进行培养并传代,观察滑膜细胞生长状况、并用细胞形态学及细胞免疫化学鉴定。结果:用酶消化法培养膝骨关节炎滑膜细胞,方法简单、成功率高、细胞形态典型。结论:单一的胶原酶消化法是一种有效的滑膜细胞原代培养的方法,可以满足一般实验需求。     

PVT1促进PAH大鼠肺动脉平滑肌细胞增殖和迁移的作用机制研究

摘要 目的：研究浆细胞瘤多样异位基因1（PVT1）在肺动脉高压（PAH）大鼠中对于肺动脉平滑肌细胞(PASMCs)增殖和迁移的作用及其可能的机制。方法：将16只成年雄性SD大鼠随机分为肺动脉高压组（PAH组）和对照组,每组8只大鼠。PAH组大鼠通过单次项背部皮下注射MCT溶液造模,对照组大鼠给予单次项背部皮下注射等量生理盐水。通过胸右心室穿刺法测量右心室压力。取各组大鼠肺组织,并进行原代肺动脉平滑肌细胞分离培养。通过RT-qPCR和Western blot检测PVT1及Fxr1在PAH组织及PASMCs中的表达水平;通过HE染色评估PAH组织的血管壁形态;免疫荧光法检测HPASMC的纯度;CCK-8法和伤口愈合迁移实验检测PASMCs增殖和迁移情况。结果：与对照组相比,PAH组大鼠肺组织血管壁厚度偏厚、肺动脉压显著升高（P<0.05）。PVT1在PAH组大鼠的PAH组织和PASMCs中的表达水平显著上调（P<0.05）,且其表达与肺动脉压呈正相关。与对照组相比,转染sh-PVT1的PASMCs显示出较低的细胞活力,同时转染sh-PVT1有效敲低了PASMCs中PVT1的表达水平（P<0.01）。与对照组相比,PVT1的敲低抑制了PASMCs迁移能力（P<0.01）。在转染pcDNA-PVT1的PASMCs中发现较高的增殖能力,PVT1的过表达促进了PASMCs迁移能力（P<0.01）。与对照组相比,Fxr1在PAH模型组的PAH组织和PASMCs中的表达水平显著上调（P<0.01）。结论：PVT1通过调节Fxr1的表达促进PASMCs的增殖和迁移,PVT1可能是PAH诊断和预测指标。     

自噬抑制剂氯奎对低氧诱导肺动脉平滑肌细胞增殖的影响

目的：探讨自噬抑制刺氯喹（cQ）在低氧（hypoxia）调节肺动脉平滑肌细胞（PASMCs）增殖中的作用。方法：将体外培养的大鼠PASMCs分为4组：正常对照组、1％低氧组、50μmol／L氯喹＋1％低氧组、50ttmol／L氯喹组。MTF方法检测各组的PASMCs增殖率;MDC染色检测细胞自噬空泡的变化;Westernblot方法检测微管相关蛋白轻链3（LC3）蛋白的表达变化;划痕法检测细胞迁移的变化。结果：与对照组比较,氯喹组的PASMCs细胞增殖率无明显变化。与对照组比较,1％低氧组PASMCs增殖率明显增加,细胞内出现大量自噬空泡,细胞迁移速度明显增加。细胞LC3-Ⅱ蛋白表达增强。与1％低氧组比较,氯喹与低氧联合作用时细胞自噬空泡的积聚以及rE3．II蛋白表达增强,但细胞增殖率和迁移明显降低。结论：低氧激活自噬过程并促进了PASMCs增殖和迁移,而自噬抑制剂氯喹在一定程度上通过抑制自噬进程,达到抑制肺动脉平滑肌细胞增殖和迁移的作用。     

Fractalkine对大鼠肺动脉平滑肌细胞增殖的影响

目的：观察fractalkine（FKN）对体外培养的大鼠肺动脉平滑肌细胞（PASMCs）增殖的影响。方法：体外培养大鼠PASMCs,加入不同浓度（10-^10、10-^9和10-^8 mol／L）的FKN处理12h、24h和48h,采用四唑盐（MTT）法检测细胞增殖,流式细胞术（FCM）检测细胞周期。结果：MTT试验显示FKN显著促进大鼠PASMCs增殖,此作用呈浓度依赖性。FCM分析显示FKN使S期细胞比例和增殖指数P1值增加。FKN处理PASMCs 12h后,其S期细胞比例和H值即出现增加,24h达高峰。结论：FKN呈浓度依赖方式促进大鼠PASMCs增殖。     

Regulation and function of Cav3.1 T-type calcium channels in IGF-I-stimulated pulmonary artery smooth muscle cells

Arterial smooth muscle cells enter the cell cycle and proliferate in conditions of disease and injury, leading to adverse vessel remodeling. In the pulmonary vasculature, diverse stimuli cause proliferation of pulmonary artery smooth muscle cells (PASMCs), pulmonary artery remodeling, and the clinical condition of pulmonary hypertension associated with significant health consequences. PASMC proliferation requires extracellular Ca(2+) influx that is intimately linked with intracellular Ca(2+) homeostasis. Among the primary sources of Ca(2+) influx in PASMCs is the low-voltage-activated family of T-type Ca(2+) channels; however, up to now, mechanisms for the action of T-type channels in vascular smooth muscle cell proliferation have not been addressed. The Ca(v)3.1 T-type Ca(2+) channel mRNA is upregulated in cultured PASMCs stimulated to proliferate with insulin-like growth factor-I (IGF-I), and this upregulation depends on phosphatidylinositol 3-kinase/Akt signaling. Multiple stimuli that trigger an acute rise in intracellular Ca(2+) in PASMCs, including IGF-I, also require the expression of Ca(v)3.1 Ca(2+) channels for their action. IGF-I also led to cell cycle initiation and proliferation of PASMCs, and, when expression of the Ca(v)3.1 Ca(2+) channel was knocked down by RNA interference, so were the expression and activation of cyclin D, which are necessary steps for cell cycle progression. These results confirm the importance of T-type Ca(2+) channels in proper progression of the cell cycle in PASMCs stimulated to proliferate by IGF-I and suggest that Ca(2+) entry through Ca(v)3.1 T-type channels in particular interacts with Ca(2+)-dependent steps of the mitogenic signaling cascade as a central component of vascular remodeling in disease.     

15-HETE protects rat pulmonary arterial smooth muscle cells from apoptosis via the PI3K/Akt pathway

15-Hydroxyeicosatetraenoic acid (15-HETE), a metabolic product of arachidonic acid (AA), plays an important role in pulmonary vascular smooth muscle remodeling. Although its effects on the apoptotic responses are known, the underlying mechanisms are still poorly understood. Since Akt is a critical regulator of cell survival and vascular remodeling, there may be a crosstalk between 15-HETE anti-apoptotic process and PI3K/Akt survival effect in rat pulmonary arterial smooth muscle cells (PASMCs). To test this hypothesis, we studied the effect of 15-HETE on cell survival and apoptosis using Western blot, cell viability measurement, nuclear morphology determination, TUNEL assay and mitochondrial potential analysis. We found that activation of the PI3K/Akt signaling system was necessary for the 15-HETE to suppress PASMC apoptosis and improve cell survival. Our results indicated that 15-HETE inhibited the apoptotic responses of PASMCs, including morphological alterations, mitochondrial depolarization and the expression apoptosis-specific proteins. These effects were likely to be mediated through the activation of PI3K/Akt. Two downstream signal molecules of PI3K/Akt were identified. Both FasL and Bad were down-regulated by 15-HETE and 15-HETE phosphorylated Bad. These changes depended on the PI3K/Akt signaling pathway in PASMCs. Thus a signal transduction pathway was demonstrated which is necessary for the effects of 15-HETE in protection PASMCs from apoptosis.     

Puerarin induces mitochondria-dependent apoptosis in hypoxic human pulmonary arterial smooth muscle cells

Background

Pulmonary vascular medial hypertrophy in hypoxic pulmonary arterial hypertension (PAH) is caused in part by decreased apoptosis in pulmonary artery smooth muscle cells (PASMCs). Puerarin, an isoflavone purified from the Chinese medicinal herb kudzu, ameliorates chronic hypoxic PAH in animal models. Here we investigated the effects of puerarin on apoptosis of hypoxic human PASMCs (HPASMCs), and to determine the possible underlying mechanisms.

Methodology/Principal Findings

HPASMCs were cultured for 24 h in normoxia or hypoxia (5% O₂) conditions with and without puerarin. Cell number and viability were determined with a hemacytometer or a cell counting kit. Apoptosis was detected with a TUNEL test, rhodamine-123 (R-123) fluorescence, a colorimetric assay, western blots, immunohistochemical staining and RT-PCR. Hypoxia inhibited mitochondria-dependent apoptosis and promoted HPASMC growth. In contrast, after puerarin (50 µM or more) intervention, cell growth was inhibited and apoptosis was observed. Puerarin-induced apoptosis in hypoxic HPASMCs was accompanied by reduced mitochondrial membrane potential, cytochrome c release from the mitochondria, caspase-9 activation, and Bcl-2 down-regulation with concurrent Bax up-regulation.

Conclusions/Significance

Puerarin promoted apoptosis in hypoxic HPASMCs by acting on the mitochondria-dependent pathway. These results suggest a new mechanism of puerarin relevant to the management of clinical hypoxic pulmonary hypertension.     

15-Hydroxyeicosatetraenoic acid (15-HETE) protects pulmonary artery smooth muscle cells from apoptosis via inducible nitric oxide synthase (iNOS) pathway

15-Hydroxyeicosatetraenoic acid (15-HETE), one of many important metabolic products of arachidonic acid (AA) catalyzed by 15-lipoxygenase, plays an important role in pulmonary vascular smooth muscle remodeling. We have previously shown its unsubstituted effects on the apoptotic responses of pulmonary artery smooth muscle cells (PASMCs), but the underlying mechanisms are still poorly manifested. Previous studies have shown that inducible nitric oxide synthase (iNOS) plays an important protective role against sepsis-induced pulmonary apoptosis. Therefore, the purpose of this study is to determine whether 15-HETE anti-apoptotic process is mediated through the iNOS pathway in rat PASMCs. To test this hypothesis, we studied the contribution of iNOS to the 15-HETE induced anti-apoptotic responses using cell viability measurement, Western blot, mitochondrial potential analysis, nuclear morphology determination and TUNEL assay. Our results showed that both exogenous and endogenous 15-HETE up-regulated iNOS protein and mRNA expression and 15-HETE enhanced the cell survival, attenuated mitochondrial depolarization, up-regulated the expression of Bcl-2 and procaspase-3 in PASMCs under serum-deprived condition. These effects were reversed by iNOS inhibitor SMT or l-canavanine. Taken together, our data indicates that iNOS is a novel signaling transduction pathway, which is necessary for the effects of 15-HETE in protection PASMCs from apoptosis and may be an important mechanism underlying the treatment of pulmonary artery hypertension and also provides a novel therapeutic insight in future.     

Over-expression of PKGIα inhibits hypoxia-induced proliferation, Akt activation, and phenotype modulation of human PASMCs: the role of phenotype modulation of PASMCs in pulmonary vascular remodeling

The proliferation of pulmonary artery smooth muscle cells (PASMCs) plays a role in pulmonary vascular remodeling (PVR). Recently, it was shown that vascular smooth muscular cell phenotype modulation is important for their proliferation in other diseases. However, little is known about the role of human PASMC phenotype modulation in the proliferation induced by hypoxia and its molecular mechanism during PVR. In this study, we found using primary cultured human PASMCs that hypoxia suppressed the expression of endogenous PKGIα, which was reversed by transfection with a recombinant adenovirus containing the full-length cDNA of PKGIα (Ad-PKGIα). Ad-PKGIα transfection significantly attenuated the hypoxia-induced downregulation of the expression of smooth muscle α-actin (SM-α-actin), myosin heavy chain (MHC) and calponin in PASMCs, indicating that hypoxia-induced phenotype modulation was blocked. Furthermore, flow cytometry and ³H-TdR incorporation demonstrated that hypoxia-induced PASMC proliferation was suppressed by upregulation of PKGIα. These results suggest that enhanced PKGIα expression inhibited hypoxia-induced PASMC phenotype modulation and that it could reverse the proliferation of PASMCs significantly. Moreover, our previous work has demonstrated that Akt protein is activated in the process of hypoxia-induced proliferation of human PASMCs. Interestingly, we found that Akt was not activated by hypoxia when PASMC phenotype modulation was blocked by Ad-PKGIα. This result suggests that blocking phenotype modulation might be a key up-stream regulatory target.     

Development of an optimized protocol for primary culture of smooth muscle cells from rat thoracic aortas

Primary culture of smooth muscle cells has been widely used as a valuable tool to study the molecular mechanisms underlying atherosclerosis and restenosis. Currently, tissue explants and enzymatic digestion methods are frequently applied to produce smooth muscle cells. Explants method is time consuming, usually taking several weeks. The enzymatic digestion method requires large amounts of proteolytic enzymes to generate enough cells for cardiovascular research. The present study reports an optimized method by combining both techniques to obtain high purity smooth muscle cells. The cultured cells exhibited the characteristic “hills and valleys” growth pattern as observed by phase contrast microscopy and showed α-SM-actin positive staining by indirect immunocytochemistry and immunofluorescence. Purity of the cells is guaranteed by the lack of von Willebrand Factor immunoreactivity. Finally, the cultured cells well proliferate on oxidized-LDL stimulation, suggesting the practical utility of this new method.